- Citations, last 5 years
- 3
- Works, last 5 years
- 11
- h-index
- 17
- Scientists listed
- 2
- Grants since 2016
- 93
Grants received
2025–2026 · grant · Standard Grant
SBIR Phase I: Streamlining Liquid Biopsy Sample Preparation Through Automated Bisulfite Conversion
Rachelle Turiello · ID Genomics (United States) · funded by National Science Foundation
2025–2027 · cooperative agreement · Cooperative Agreement
SBIR Phase II: Rapid, End-to-end Sample Preparation for Sequencing Applications
Ryan Montes · ID Genomics (United States) · funded by National Science Foundation
2025–2026 · research · R43
Harnessing mRNA Vaccine Technology for Precision Antimicrobial Delivery
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2025–2026 · research · R41
CARDIAC CASCADE: Cardiomyopathy and Arrhythmia Risk Dissemination through Innovative Family Sharing
Lisa L Shah · ID Genomics (United States) · funded by National Institutes of Health
2025–2027 · research · R44
Next generation spatial genomics tools for the human brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2024–2025 · research · R44
Pioneering assays for spatially-resolved single-cell multiomics
Lin Pham · ID Genomics (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
Michael T Barrett · ID Genomics (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Development of a lung cancer subtyping diagnostic
Harold R Garner · ID Genomics (United States) · funded by National Institutes of Health
2024–2025 · research · R42
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Moran Snir · ID Genomics (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Pioneering assays for spatially-resolved single-cell multiomics
George Christopher Hartoularos · ID Genomics (United States) · funded by National Institutes of Health
2024–2027 · research · R42
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Moran Snir · ID Genomics (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
Michael T Barrett · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Multi-modal spatial genomics in the mouse and human brains
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Spatial genomics analysis of tumor samples
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Spatial single cell analysis of the human Alzheimer's Disease brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Spatial genomics analysis of tumor samples
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Multi-modal spatial genomics in the mouse and human brains
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
AI-based AML risk stratification using next generation cytogenomics
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
Michael T Barrett · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2023–2024 · research · R43
Target Insertion Amplification and Sequence (TIAS): A novel targeted sequencing technology that performs rapid target enrichment and next generation sequencing sample preparation simultaneously
Phillip Neal Gray · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
AI-based AML risk stratification using next generation cytogenomics
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
A portable quantitative polymerase chain reaction platform (qPCR) for rapid detection of pathogens impacting model organisms in animal facilities
Scott Franklin Geller · ID Genomics (United States) · funded by National Institutes of Health
2023 · research · R43
Biological validation of phage host-range identified by proximity guided metagenomics
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Spatial single cell analysis of the human Alzheimer's Disease brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2022–2023 · research · R44
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
Sophie Zaaijer · ID Genomics (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2022–2023 · research · R43
Development of Blood-based Circular RNA Biomarkers for Alzheimer's Disease
Julie Collens · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells
Atray Dixit · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A next-generation method for cytogenomics using Hi-C proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A next-generation method for cytogenomics using Hi-C proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R21
Device for Preservation of Cell Free RNA in Saliva
Shivani Nautiyal · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R21
Device for Preservation of Cell Free RNA in Saliva
Shivani Nautiyal · ID Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2020–2021 · research · R44
Next generation cytogenomics using proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2020–2021 · research · R44
A proximity ligation method to track mobile element hosts
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2020–2025 · research · R01
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
Christina Chambers · ID Genomics (United States) · funded by National Institutes of Health